the cure for baldness must be really really really hard to find
Good News -- I just called Aderans Research Institute in Atlanta
Collapse
X
-
-
I will be immensely surprised if a company doesnt buy out Aderans.
I mean if Shisedo can spend millions on Replicel and they have only just finished Phase I, then I'm sure a company will be willing to buy Aderans who is heading into Phase III with two successful trials backing them and a working protocol.
Why on earth does MILLIONS get spend on worthless make-up products for women and when the cure for baldness is in question nobody seems to give a ****.
There is something fishy going on.
I bet the chances are , they did grow hair, but it was of poor quality.Comment
-
Looking at their results they were very average (like Replicel's so far)
If it wasn't yielding results then probably wasn't worth continuing and arguably not a huge loss.
That said though, hopefully someone can but them out and carry the work onComment
-
Yup, but they did quote good percentages for terminal hair...Comment
-
Yeah probably just a crap product.
Looking at their results they were very average (like Replicel's so far)
If it wasn't yielding results then probably wasn't worth continuing and arguably not a huge loss.
That said though, hopefully someone can but them out and carry the work onComment
-
Or... maybe he was *facepalm* not telling the complete story when he said "we're having good results".
Man this is really ****ed up, Shiesedo just invested a massive amount into Replicel, I dont see why the same cant happen with Aderans??? They're even closer to market than Replicel!
I very much hope that Spencer's reassurances that it wouldn't require a huge investment to get the ARI process through phase III turn out to be correct.Comment
-
Comment
-
Maybe someone (Shiesedo?) will buy the rights to ARI and combine the process with Replicel? I mean, they essentially work in a very similar fashion to each other. Wishful thinking and groundless speculation, yes, but not impossible.
I very much hope that Spencer's reassurances that it wouldn't require a huge investment to get the ARI process through phase III turn out to be correct.Comment
-
A wig company decided that they were more comfortable with the ROI and business model of Bosely than with a research team (ARI). Most likely has zero to do with the state of research. My question is, does Aderans have rights to the research? That is what could really hold things up. Does Aderans own the rights to the research that ARI has done and would like to continue to do?Comment
-
I think we can assume that Aderans, at the least, owns the lab and equipment (hence the fire sale). What about the intellectual property?Comment
-
A big shout out to Joe for expressing exactly how we all felt about the news! I hope Aderans Board of Director watch this video with a great burden of guiltComment
-
Hmmm....on this note, keep in mind that Cosmo's Methylene Blue product is garnering interest from big pharma and seems to be their primary "star" drug. (But I could be wrong).
If Big Pharma buys Cosmo with view to getting access to the MB product, given they've shown no interest in MPB, it wouldn't surprise me if they killed CB in the pipeline.
God, I'm such an asshole.Comment
-
Comment